[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631677":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":40,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":10,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":58,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Sohag University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"patient with bladder cancer recieving radiotherapy and the treatment related events",null,[12],"Radiation: Radiotherapy followed by chemotherapy",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"RADIATION","Radiotherapy followed by chemotherapy","it is observational study for patient recieved defentive radiotherapy",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"heba elsagheer","CONTACT","0201062162612","hebaelsagheer@yahoo.com",[26],{"facility":27,"status":10,"city":28,"state":10,"zip":10,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Sohag University Hospitals","Sohag","Egypt",{"type":31,"coordinates":32},"Point",[33,34],31.69478,26.55695,{"lat":34,"lon":33},[37],{"name":21,"role":22,"phone":38,"phoneExt":10,"email":39},"00201062162612","hebaelsagheer@yahoo.cm",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Heba Ali Elsagheer","proffesor clinical oncology","100631677",false,"NCT07503795","Outcomes of Definitive Radiotherapy for Bladder Cancer","Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center","Inclusion Criteria:\n\n* Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy\n\nExclusion Criteria:\n\n* Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.","ALL",{"count":52,"type":53},300,"ESTIMATED","OBSERVATIONAL","this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer",[57],"Bladder Cancer (BC)","NOT_YET_RECRUITING","2026-03-26",{"date":61,"type":62},"2026-03-31","ACTUAL",{"date":64,"type":53},"2026-04-01",{"date":66,"type":53},"2027-06-01",{"name":5,"class":6},1]